Login to Your Account

Pharma: Other News To Note

Wednesday, April 3, 2013
• UCB SA, of Brussels, Belgium, said its Canadian subsidiary received Health Canada approval for Neupro (rotigotine), a non-ergolinic dopamine agonist in patch form.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription